| Health / Medical Topics |
PLX4032
A drug used to treat advanced melanoma that has a mutated (changed) form of a cell protein called BRAF. It is also being studied in the treatment of other types of cancer. PLX4032 blocks this mutated protein, which may stop the growth of cancer cells. It is a type of kinase inhibitor and a type of targeted therapy agent. Also called BRAF (V600E) kinase inhibitor RO5185426, RG7204, vemurafenib, and Zelboraf. (NCI Dictionary)
YOU MAY ALSO LIKE
Human PLVAP wild-type allele is located in the vicinity of 19p13.2 and is approximately 26 kb in length. This allele, which encodes…
This gene may be involved in caveolae structure.
The part of the gut between the mouth and the esophagus, the throat.
An artificial radioactive element with long half-life, Plutonium-239 is produced by bombarding uranium-238 with slow neutrons and is used as the explosive…
The end of a microtubule where tubulin polymerization occurs.
The end of an actin filament that is polymerizing at a faster rate.
